Hospital autopsy: standardised questionnaire survey to determine junior doctors' perceptions.

1985;8:142-7. 27 Crawford SM, Buckman R. Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study. Med Oncol Tumor Pharmacother 1986;3:39-42. 28 Dalzell AM, Bartlett H, Lilleyman JS. Nabilone: an alternative antiemetic for cancer chemotherapy. Arch Dis Child 1986;61:502-5. 29 Einhorn LH, Nagy C, Furnas B, Williams SD. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy. J Clin Pharmacol 1981;21:64-9S. 30 George M, Pejovic MH, Thuaire M, Kramar A, Wolff JP. Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin. Biomed Pharmacother 1983;37:24-7. 31 Herman TS, Einhorn LH, Jones SE, Nagy C, Chester AB, Dean JC, et al. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med 1979;300:1295-7. 32 McCabe M, Smith FP, Macdonald JS, Woolley PV, Goldberg D. Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy. Invest New Drugs 1988;6:243-6. 33 Neidhart JA, Gagen MM, Wilson HE, Young DC. Comparative trial of the antiemetic effects of THC and haloperidol. J Clin Pharmacol 1981;21:3842S. 34 Steele N, Gralla RJ, Braun DWJr, Young CW. Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis. Cancer Treat Rep 1980;64:219-24. 35 Hubbard JR, Franco SE, Onaivi ES. Marijuana: medical implications. Am Fam Physician 1999;60:2583-93. 36 Seipp CA, Chang AE, Shiling DJ, Rosenberg SA. In search of an effective antiemetic: a nursing staff participates in marijuana research. Cancer Nursing 1980 Aug:271-6. 37 Moore RA, Gavaghan D, Tramèr MR, Collins S, McQuay HJ. Size is everything—the impact of event rate variation on clinical trials and metaanalysis. Pain 1998;78:208-16. 38 Moore RA, Tramèr MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitative systematic review of topically-applied non-steroidal anti-inflammatory drugs. BMJ 1998;316:333-8.